NCT07019714 is a NA clinical trial of Daoyin Technique in Idiopathic Pulmonary Fibrosis, sponsored by Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.

What drugs are being tested in NCT07019714?

Interventions in NCT07019714: Daoyin Technique, Routine Comprehensive Training.

What condition does NCT07019714 study?

NCT07019714 studies Idiopathic Pulmonary Fibrosis.

Is NCT07019714 still recruiting?

NCT07019714 is currently not yet recruiting. Last updated 13 June 2025.

Last reviewed 2025-06-13 · How we verify

NCT07019714

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Daoyin Technique for Improving Exercise Endurance in IPF

Not yet recruiting NA Last updated 13 June 2025

What this trial tests

NA trial testing Daoyin Technique in Idiopathic Pulmonary Fibrosis in 236 participants. Not yet recruiting.

Timeline

30 June 2025

Primary endpoint
30 June 2028

30 December 2028

Quick facts

Lead sponsor	Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	236
Start date	30 June 2025
Primary completion	30 June 2028
Estimated completion	30 December 2028
Sites	1 location across China

Drugs / interventions tested

Daoyin Technique
Routine Comprehensive Training

Conditions studied

Idiopathic Pulmonary Fibrosis — all drugs for Idiopathic Pulmonary Fibrosis →

Sponsor

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

Who can join

Adults 40 to 85, any sex, with Idiopathic Pulmonary Fibrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is based on the previously constructed digital rehabilitation management platform, scientifically evaluating the clinical efficacy of guided technology in improving IPF exercise endurance, and forming high-quality clinical evidence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Idiopathic Pulmonary Fibrosis

Currently open trials in the same condition.

NCT05988463 — Dose-Escalation Study of Artesunate Patients With IPF · Phase 1 · recruiting
NCT06241560 — A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in · Phase 2 · recruiting
NCT07407543 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Cauc · Phase 1 · recruiting
NCT07036523 — A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) · Phase 2 · recruiting
NCT07225296 — A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics o · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07019714 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Last refreshed: 13 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07019714.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing